WilmerHale Advises Argos Therapeutics in Asset Sale to Affiliate of SCM Lifescience and Genexine
Mar 12, 2019 - Targeted News Service
WilmerHale, a law firm, issued the following news:
WilmerHale acted as lead counsel to immunotherapy company Argos Therapeutics, Inc. (OTCPK: ARGS.Q) in the sale of substantially all of its assets to an affiliate of SCM Lifescience Co., Ltd. and Genexine, Inc.
After two decades of refining its technology, Argos faced liquidity challenges in continuing its intellectual property development mission. In order to preserve the value of its assets, Argos filed for Chapter 11 bankruptcy in ...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
